From: A clinical trial of enteral Levetiracetam for acute seizures in pediatric cerebral malaria
Parameter | Estimate | SE of Estimate | Median | BS 2.5th | BS 97.5th |
---|---|---|---|---|---|
V (L/kg) | 0.711 | 0.06 | 0.696 | 0.562 | 0.825 |
CL (L/h/kg0.75) | 0.169 | 0.015 | 0.171 | 0.145 | 0.206 |
KA (hr−1) | 1.37 | 0.286 | 1.25 | 0.553 | 2.37 |
Lag time (h) | 1.96 | 0.038 | 1.54 | 0.258 | 3.97 |
SCR factor | −1.37 | 0.343 | − 1.34 | −2.06 | −0.631 |
Between Subject Variability | |||||
BSV-V | 25% | 5% | 22% | 5% | 39% |
BSV-CL | 43% | 6% | 42% | 28% | 56% |